Patent ID: 7196103
Filing Date: 2007-03-27
Classification: A61P,C07D

Abstract:
1. A compound of the formula I, wherein, R R8 is provided that when R Q is a direct bond, —(C wherein R R R R R R R14 is halogen, —OH, ═O, —(C  wherein R V is G is a direct bond, —(CH n and m are independently of one another identical or different and are the integers zero, 1, 2, 3, 4, 5 or 6; M is R R11 and R12 are independently of one another identical or different and are R11 and R12 together with the nitrogen to which they are bonded can form a 4- to 8-membered monocyclic heterocyclic ring which in addition to the nitrogen can contain one or two identical or different ring heteroatoms chosen from oxygen, sulfur and nitrogen, wherein the heterocyclic ring is unsubstituted or mono-, di- or trisubstituted independently of one another by R13; R13 is halogen, —NO R R15 and R16 are independently of one another hydrogen, —(C R17 is —(C provided that at least one of the residues R provided that R11 and R12 together with the nitrogen to which they are bonded optionally form a 4- or 8-membered monocyclic heterocyclic ring or [1,4]oxazepane, [1,3]oxazepane, or [1,3]thiazepane, which in addition to the nitrogen can contain one or two identical or different ring heteroatoms chosen from oxygen, sulfur and nitrogen, wherein the ring is unsubstituted or mono-, di- or trisubstituted independently of one another by R13; or provided that R17 is —(C provided that R13 is —(C provided that R11 is hydrogen and R12 is —O—R17; or a stereoisomer or a mixture of stereoisomer thereof in any ratio, or its physiologically tolerable salt.